CG
KDNY

Carmignac Gestion’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Carmignac Gestion’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-56,842
Closed -$2.18M – 175
2023
Q2 		$2.18M Buy
+56,842
New +$1.46M 0.04% 101

Carmignac Gestion's KDNY Position: Q3 2023 in Review

Carmignac Gestion sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 56,842 shares — an estimated $2.18M sold.

Carmignac Gestion first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $2.18M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

  • Carmignac Gestion reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Carmignac Gestion sold 56,842 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.18M.
  • Carmignac Gestion first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Carmignac Gestion's Chinook Therapeutics, Inc. Common Stock position peaked at $2.18M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Carmignac Gestion's 13F filing for Q3 2023, filed 13 Nov 2023.